Award
National Heart, Lung, and Blood Institute 1R44HL180034-01A1
Heart Muscle Regeneration
Recipient
Not specified
Award Amount
$1,290,338.00
Ceiling
$1,290,338.00
Awarded
September 19, 2025
Identifier
1R44HL180034-01A1
NIH NHLBI funded project to develop and evaluate a gene therapy for heart attack patients to prevent heart failure, including preclinical large animal studies, from 2025 to 2027.
Description
The project involves developing a therapy for heart attack patients to prevent heart failure. It includes preclinical studies in large animals and aims to evaluate dosing strategies and safety of a gene therapy (JBT-miR2-ADD). The project duration is approximately from September 2025 to July 2027.